Russian Direct Investment Fund (RDIF), the agency that is spearheading Sputnik V vaccine manufacturing and supply partnerships globally, said India has become the 60th country to approve Sputnik V. “RDIF has created partnerships with a number of India’s leading pharmaceutical companies for production of Sputnik V which will provide for both vaccination of the population in India and global distribution of the Russian vaccine.